Free equity investment tool of Japanese companies

Financial Indicator Details

Annual

First quarter

Second quarter

Third quarter

Sponsored Link

Related Company

本州化学工業

Sosei Group

NIPPON SEIRO

関東電化工業

Kawaguchi Chemical Industry

Chiome Bioscience

KAWAKAMI PAINT MFG.

シンバイオ製薬

Carna Biosciences

廣貫堂

日本化学工業

CHISSO

RaQualia Pharma

Nippon Shikizai

EDIUNET Related Ranking

EDIUNET

EDIUNET Credit Rating

EDIUNET Industry Avg

EDIUNET Prefectures

Yuho! Industry

EDIUNET Rating News

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

1/28 Retail Trade (CAWACHI:A etc...

1/27 Banks (The Awa Bank:BBB→A)

1/23 Chemicals (Milbon:AA→AAA)

1/21 Glass & Ceramics Products (..

1/21 Machinery (TSUDAKOMA:C)

1/21 Other Services (Netindex.:CC)

1/20 Other Products (Kurogane Kos..

1/20 Wholesale Trade (リーバイ・..

1/20 Other Services (川崎地質:BB→..

1/17 Chemicals (Kawaguchi Chemica..

 RSS

 Company RSS

 Daily RSS

Sponsored Link

Recently Download Chart

日本セラミック

日本セラミック

日本セラミック

日本セラミック

日本セラミック

Financial Indicator Details: シンバイオ製薬 (Annual )

Two or more periods are displayed by each of financial indicator collectively.Two or more companies can be compared and financial indicator data can also be downloaded.

【Analysis Menu】 Outline Statement Rating Indicator Download

Sponsored Link

*Free Download Financial Indicator data

Indicator Summary: シンバイオ製薬 (Annual )

Non-Consolidated :Indicator Non-Consolidated

Profitability	2009-12-31	2010-12-31	2011-12-31	2012-12-31
Net profit margin (Industry Average)	-18.29% (-4.34%)	-44.29% (-5.37%)	-111.79% (-10.69%)	-88.64% (8.92%)
C/F margin (Industry Average)	-17.74% (1.04%)	-51.99% (0.82%)	-110.20% (-0.81%)	-84.80% (-39.63%)
ROA (Industry Average)	-5.11% (0.92%)	-15.06% (1.42%)	-28.99% (-0.27%)	-31.49% (1.53%)
ROE (Industry Average)	-5.37% (-0.46%)	-15.73% (1.81%)	-31.85% (3.42%)	-35.37% (2.62%)
Growth	2009-12-31	2010-12-31	2011-12-31	2012-12-31
Equity growth (Industry Average)	- (3.64%)	0.72% (3.03%)	61.76% (0.04%)	-25.82% (3.91%)
Sales growth (Industry Average)	- (-)	21.73% (6.70%)	29.79% (0.75%)	3.87% (-1.74%)
Net profit growth (Industry Average)	- (166.48%)	-194.80% (43.48%)	-227.56% (-47.04%)	17.63% (62.14%)
Operating C/F growth (Industry Average)	- (89.80%)	-256.76% (77.44%)	-175.07% (-44.41%)	20.05% (46.89%)
Stability	2009-12-31	2010-12-31	2011-12-31	2012-12-31
Capital adequacy (Industry Average)	95.14% (57.65%)	95.78% (57.17%)	91.02% (55.93%)	89.03% (57.57%)
Liquidity ratio (Industry Average)	2,054.13% (276.75%)	2,368.28% (266.94%)	1,111.64% (314.47%)	905.66% (233.84%)
C/F ratio current liabilities (Industry Average)	-97.17% (53.10%)	-23.59% (31.35%)	-31.13% (76.77%)	-36.09% (31.87%)
Quick ratio (Industry Average)	1,900.15% (183.78%)	1,304.45% (174.83%)	731.11% (228.06%)	783.27% (169.77%)
Turnover	2009-12-31	2010-12-31	2011-12-31	2012-12-31
Receivables turnover (Industry Average)	- (98.39day)	1.49day (95.88day)	31.49day (98.58day)	27.64day (67.18day)
Inventory turnover (Industry Average)	- (48.43day)	- (47.43day)	40.23day (50.67day)	30.78day (38.21day)
Payable turnover (Industry Average)	- (51.63day)	0.29day (51.13day)	59.91day (53.57day)	61.56day (34.24day)
Working capita turnover (Industry Average)	- (95.19day)	1.19day (92.19day)	11.81day (95.69day)	-3.13day (71.15day)
Stock etc.	2009-12-31	2010-12-31	2011-12-31	2012-12-31
Market Value growth (Industry Average)	- (34.46%)	- (3.11%)	- (-3.30%)	- (24.19%)
Dividend Yield (Industry Average)	- (0.09%)	- (0.10%)	- (0.16%)	- (0.15%)
PER (Industry Average)	- (27.80%)	- (13.58%)	- (22.26%)	- (26.42%)
PBR (Industry Average)	- (1.21%)	- (1.17%)	- (1.08%)	- (1.54%)
PCFR (Industry Average)	- (0.62%)	- (0.23%)	- (0.08%)	- (4.97%)
PSR (Industry Average)	- (4.34%)	- (3.67%)	- (4.37%)	- (10.14%)

Financial Indicator Details: シンバイオ製薬

Non-Consolidated :Indicator Non-Consolidated

Indicator	2009-12-31	2010-12-31	2011-12-31	2012-12-31
Profitability
Net profit margin	-18.29%	-44.29%	-111.79%	-88.64%
C/F margin	-17.74%	-51.99%	-110.20%	-84.80%
ROA	-5.11%	-15.06%	-28.99%	-31.49%
ROE	-5.37%	-15.73%	-31.85%	-35.37%
Recurring margin	-17.97%	-44.02%	-111.31%	-88.43%
EBIT margin	-18.14%	-44.10%	-111.63%	-88.54%
EBITDA margin	-17.77%	-43.65%	-111.19%	-88.10%
NOPAT margin	-10.88%	-26.46%	-66.97%	-53.12%
Sales SG rates	-	16.42%	65.01%	69.66%
Sales SG&A rates	117.46%	125.83%	144.80%	117.30%
Sales R&D expenses rates	-	-	-	-
Sales depreciation rates	0.36%	0.44%	0.43%	0.43%
Capital expenditures net sales ratio	-0.28%	-0.97%	-0.07%	-0.09%
Indicator	2009-12-31	2010-12-31	2011-12-31	2012-12-31
Growth
Growth rate of cash	-	-40.68%	96.96%	-0.41%
Equity growth	-	0.72%	61.76%	-25.82%
Total assets growth	-	0.04%	70.21%	-24.17%
Sales growth	-	21.73%	29.79%	3.87%
Net profit growth	-	-194.80%	-227.56%	17.63%
Operating C/F growth	-	-256.76%	-175.07%	20.05%
Recurring profit growth	-	-198.20%	-228.17%	17.47%
EBIT growth	-	-195.93%	-228.51%	17.60%
EBITDA growth	-	-198.91%	-230.60%	17.69%
NOPAT growth	-	-195.93%	-228.51%	17.60%
Operating expenses growth	-	-	-	-
Indicator	2009-12-31	2010-12-31	2011-12-31	2012-12-31
Stability
Capital adequacy	95.14%	95.78%	91.02%	89.03%
Liquidity ratio	2,054.13%	2,368.28%	1,111.64%	905.66%
C/F ratio current liabilities	-97.17%	-23.59%	-31.13%	-36.09%
Quick ratio	1,900.15%	1,304.45%	731.11%	783.27%
Fixed ratio	0.32%	0.53%	0.26%	0.28%
D/E ratio	-	-	-	-
Loan to Value Ratio	-	-	-	-
Business investment C/F ratio	1.61%	1.87%	0.06%	0.11%
Liabilities with interest growth	-	-	-	-
Indicator	2009-12-31	2010-12-31	2011-12-31	2012-12-31
Turnover
Cash turnover	1,195.77day	582.62day	884.12day	847.62day
Receivables turnover	-	1.49day	31.49day	27.64day
Inventory turnover	-	-	40.23day	30.78day
Fixed assets turnover	4.09day	5.51day	3.37day	2.56day
Total asset turnover	1,305.61day	1,073.06day	1,407.26day	1,027.26day
Payable turnover	-	0.29day	59.91day	61.56day
Capital turnover	1,035.20day	934.12day	1,168.42day	1,124.79day
Equity turnover	1,242.20day	1,027.82day	1,280.99day	914.64day
Working capita turnover	-	1.19day	11.81day	-3.13day
Indicator	2009-12-31	2010-12-31	2011-12-31	2012-12-31
Balance sheet
Cash etc.	¥ 3 B	¥ 2 B	¥ 4 B	¥ 4 B
Accounts receivable-trade	-	¥ 5 M	¥ 162 M	¥ 148 M
Other Current Assets	¥ 316 M	¥ 1 B	¥ 2 B	¥ 880 M
Current Assets	¥ 4 B	¥ 4 B	¥ 7 B	¥ 5 B
Tangible Assets	¥ 13 M	¥ 21 M	¥ 17 M	¥ 13 M
Intangible Assets	¥ 1 M	¥ 772 K	¥ 12 M	¥ 10 M
Investment etc.	¥ 27 M	¥ 27 M	¥ 47 M	¥ 56 M
Total Assets	¥ 4 B	¥ 4 B	¥ 7 B	¥ 5 B
Current Liabilities	¥ 205 M	¥ 177 M	¥ 645 M	¥ 598 M
Fixed Liabilities	¥ 1 M	¥ 1 M	¥ 4 M	¥ 3 M
Liabilities with interest	-	-	-	-
Net Assets	¥ 4 B	¥ 4 B	¥ 6 B	¥ 4 B
Capital stock	¥ 3 B	¥ 3 B	¥ 6 B	¥ 6 B
Capital surplus etc.	¥ 675 M	¥ 372 M	¥ 580 M	¥ -1 B
Liabilities and net assets	¥ 4 B	¥ 4 B	¥ 7 B	¥ 5 B
Indicator	2009-12-31	2010-12-31	2011-12-31	2012-12-31
Income statement
Sales	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Cost of Sales	-	¥ 238 M	¥ 1 B	¥ 1 B
Gross profit	¥ 1 B	¥ 1 B	¥ 658 M	¥ 592 M
Other income	¥ 20 M	¥ 12 M	¥ 56 M	¥ 7 M
SG&A	¥ 1 B	¥ 1 B	¥ 2 B	¥ 2 B
Other expenses	¥ 30 M	¥ 42 M	¥ 94 M	¥ 40 M
Net income	¥ -217 M	¥ -642 M	¥ -2 B	¥ -1 B
Operating income	¥ -208 M	¥ -612 M	¥ -2 B	¥ -1 B
Ordinary Income	¥ -214 M	¥ -638 M	¥ -2 B	¥ -1 B
EBITDA	¥ -211 M	¥ -633 M	¥ -2 B	¥ -1 B
Income before income taxes	¥ -214 M	¥ -638 M	¥ -2 B	¥ -1 B
Depreciation	¥ 4 M	¥ 6 M	¥ 8 M	¥ 8 M
R&D expenses	-	-	-	-
Income taxes	¥ 3 M	¥ 3 M	¥ 3 M	¥ 3 M
Indicator	2009-12-31	2010-12-31	2011-12-31	2012-12-31
Cash flow statement
Operating CF	¥ -211 M	¥ -753 M	¥ -2 B	¥ -1 B
Investment CF	¥ -3 M	¥ -115 M	¥ -117 M	¥ -410 M
Financial CF	¥ 2 B	¥ 662 M	¥ 4 B	-
Foreign Exchange Effects	¥ 3 M	¥ 1 M	¥ -24 M	¥ -1 M
Net Change in Cash	¥ 2 B	¥ -205 M	¥ 2 B	¥ -2 B
Free CF	¥ -215 M	¥ -869 M	¥ -2 B	¥ -2 B
Capital expenditures	¥ -3 M	¥ -14 M	¥ -1 M	¥ -1 M
Cash dividends paid	-	-	-	-
Repayment loans	-	-	-	-
Indicator	2009-12-31	2010-12-31	2011-12-31	2012-12-31
Shareowners' equity
Issuance of new shares	¥ 2 B	¥ 665 M	¥ 4 B	-
Dividends from surplus	-	-	-	-
Net income	¥ -217 M	¥ -642 M	¥ -2 B	¥ -1 B
Purchase of treasury stock	-	-	¥ -17 K	-
Other Change in Stockholders Equity	¥ -1 K	¥ -1 K	¥ -3 K	¥ 1 K
Other Change in Net Assets	¥ -6 M	¥ 6 M	¥ -527 K	¥ 27 M
Net Change in Net Assets	¥ 2 B	¥ 29 M	¥ 2 B	¥ -1 B

Free Download

*Free Download Financial Indicator dataMember limited service.

[Data] Net Profit Margin, Sales Growth, Equity Margin etc., 100 or more kinds of financial indicators. (*Consolidated or Non-Consolidated. two or more terms)

Sponsored Link

Related Information: シンバイオ製薬 (Annual )

Statement Type

Annual : シンバイオ製薬

First quarter : シンバイオ製薬

Second quarter : シンバイオ製薬

Third quarter : シンバイオ製薬

Analysis Menu

Outline : シンバイオ製薬

Statement : シンバイオ製薬

Rating : シンバイオ製薬

Indicator : シンバイオ製薬

Download : シンバイオ製薬

Industry Comparison Ranking

Chemicals - EDIUNET Industry Rankings

Chemicals - EDIUNET Credit Rating

Chemicals - EDIUNET Industry Avg

Comparison with a neighboring company

Tokyo - EDIUNET Prefectures

Tokyo港区 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/23	Milbon	AA→AAA	2013-12-20
1/17	Kawaguchi Chemical Indu..	BBB→BB	2013-11-30
1/17	SANKEI CHEMICAL	A	2013-11-30
1/15	HOKKO CHEMICAL INDUSTRY	BB→B	2013-11-30
1/15	Daito Pharmaceutical Co .	AA	2013-11-30 (Q2)
1/15	KAWAKAMI PAINT MFG.	B→BB	2013-11-30
1/15	旭化学工業	AA	2013-11-30 (Q1)
1/10	OSAKA ORGANIC CHEMICAL ..	BB→BBB	2013-11-30
1/10	HISAMITSU PHARMACEUTICAL	A	2013-11-30 (Q3)
1/10	AMS Life Science	BBB→BB	2013-11-30 (Q1)

EDIUNET Investment News (Chemicals)

1/23 Chemicals (Milbon:AA→AAA)

1/17 Chemicals (Kawaguchi Chemica..

1/15 Chemicals (HOKKO CHEMICAL IN..

1/10 Chemicals (OSAKA ORGANIC CHE..

1/9 Chemicals (SANKO GOSEI:A)

12/27 Chemicals (Niitaka:A)

12/18 Chemicals (KUMIAI CHEMICAL I..

12/12 Chemicals (IHARA CHEMICAL IN..

12/11 Chemicals (Konoshima Chemica..

12/10 Chemicals (NATOCO:AA)

Company Information

Ticker	Market	Industry	Month	report	Rating
シンバイオ製薬	4582	OSE JASDAQ	Chemicals	12	Annual	BB

Related Company

シンバイオ製薬 (Sales ¥ 1 B)

RaQualia Pharma (Sales ¥ 28 M)

Sosei Group (Sales -)

日本化学工業 (Sales ¥ 27 B)

Nippon Shikizai (Sales ¥ 6 B)

CHISSO (Sales -)

関東電化工業 (Sales ¥ 30 B)

本州化学工業 (Sales ¥ 13 B)

Kawaguchi Chemical Industry (Sales ¥ 6 B)

Carna Biosciences (Sales ¥ 464 M)

Chiome Bioscience (Sales ¥ 324 M)

廣貫堂 (Sales ¥ 10 B)

NIPPON SEIRO (Sales ¥ 40 B)

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .